Company Filing History:
Years Active: 2006-2008
Title: Geert Deschamps: Innovator in HCV Envelope Protein Research
Introduction
Geert Deschamps is a notable inventor based in Aalter, Belgium. He has made significant contributions to the field of biotechnology, particularly in the development of methods for the expression of hepatitis C virus (HCV) envelope proteins. With a total of three patents to his name, Deschamps has established himself as a key figure in his area of expertise.
Latest Patents
One of Deschamps' latest patents is focused on constructs and methods for the expression of recombinant HCV envelope proteins. This invention relates to vectors and methods that enable efficient expression of HCV envelope proteins in eukaryotic cells. The vectors include a coding sequence for an avian lysozyme signal peptide, which is effectively removed during the expression process. Another significant patent involves core-glycosylated HCV envelope proteins, characterized by their N-glycosylation sites. These proteins are particularly suited for diagnostic, prophylactic, and therapeutic applications.
Career Highlights
Geert Deschamps has been associated with Innogenetics N.V., a company known for its innovative approaches in the field of molecular diagnostics and therapeutic solutions. His work has contributed to advancements in understanding and treating HCV, which remains a critical area of research in virology.
Collaborations
Throughout his career, Deschamps has collaborated with notable colleagues such as Fons Bosman and Erik Depla. These partnerships have fostered a collaborative environment that enhances the research and development of HCV-related technologies.
Conclusion
Geert Deschamps is a prominent inventor whose work in HCV envelope protein research has led to significant advancements in biotechnology. His patents reflect a commitment to innovation and the pursuit of solutions for complex medical challenges.